On the other hand, Kloten et al. reported the loss of NDRG2 protein expression in human BC and low NDRG2 immunoreactivity in TNBCs [42], which goes in line with the significant downregulation we found in the BL2 subgroup. The gene discussed is CADM1; the disease is breast cancer.